SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in popularity as the community rallies around its status as a long-standing parody of Bitcoin, with users debating whether its satirical roots give it staying power as a legitimate asset. Supporters are actively pointing to its unique lore, growing holder count, and high-profile endorsements as catalysts, while others remain skeptical, fueling a polarized discussion about its long-term potential in the meme coin space.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The community is rallying behind the multichain meme project crow with knife, highlighting its deflationary burn mechanism and organic growth as primary drivers of their bullish sentiment. Discussions are dominated by high-energy engagement and a strong conviction that the token serves as a unique asset within the current meme coin landscape.

Maulcoin

Maulcoin is trending as its community aggressively pushes for a break into 'penny land,' fueled by excitement over potential airdrops and expectations of an upcoming chart listing. Supporters are actively rallying on social media to build momentum, framing the project as a long-term, community-driven alternative to typical meme coin pump-and-dump schemes.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is trending as institutional investors debate whether the sector's aggressive AI-driven rally is facing a distribution phase or a continuation setup. The community is heavily focused on the disconnect between soaring AI infrastructure capex and mounting concerns over data center cancellations, power grid constraints, and valuation premiums.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors aggressively build positions in anticipation of a transformative FDA Biologics License Application decision and pivotal clinical data readouts expected in the coming year. The community remains highly focused on the competitive potential of ivonescimab against existing immunotherapies, with intense debate ongoing regarding its high short interest and the strategic maneuvering of management ahead of key industry conferences.

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Telix Pharmaceuticals Ltd. - ADR

Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals is gaining significant investor attention following the FDA's acceptance of its NDA for its brain cancer imaging agent, with the community closely tracking upcoming regulatory milestones and board appointments that signal potential for long-term growth. Traders are actively debating the company's competitive position in the radiopharmaceutical sector and its ability to scale its commercial infrastructure alongside a promising late-stage pipeline.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is currently trending as investors weigh strong production performance and ongoing cost-synergy gains from the Marathon Oil acquisition against broader industry concerns over softening oil prices. The community is actively discussing the stock's resilience and dividend sustainability while monitoring how geopolitical tensions might influence future energy supply dynamics.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is seeing heightened community discussion as investors monitor potential ETF developments and look for signs of a broader market reversal alongside Bitcoin. While some retail participants remain cautious due to market volatility and ongoing debates over memecoin utility, others are actively accumulating tokens in anticipation of a recovery trend.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as a leading proxy for SpaceX, driven by investor optimism surrounding a potential high-valuation IPO and the company's significant equity stake acquired through recent spectrum deals. Market participants are actively debating the company's valuation metrics and the potential for a short squeeze, positioning the stock as a high-beta setup tied to the upcoming space sector catalysts.

TON (The Open Network) is a general-purpose&nbsp;blockchain that allows developers to build decentralized apps and tokens.

Toncoin

Toncoin is capturing market attention as its integration with Telegram reaches a massive user base, with traders highlighting recent sub-second network upgrades and high APY staking opportunities. Community discussion is currently centered on increased institutional adoption, including new ETP listings and strategic whale accumulation despite recent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop System and Latest Advancement in Optive AI Software

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop...

How Decentralized AI is Unlocking Value in Cardiac Diagnostics

How Decentralized AI is Unlocking Value in Cardiac Diagnostics How Decentralized AI is Unlocking Value in Cardiac Diagnostics PR Newswire VANCOUVER,BC, March 27, 2026 ISSUED ON BEHALF OF VENTRIPOINT...

Brett Hale Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) CFO Brett Hale sold 24,188 shares of Hyperfine stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the transaction, the chief financial officer directly...

Thomas Teisseyre Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) COO Thomas Teisseyre sold 24,188 shares of the stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the sale, the chief operating officer...

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

Horizon Technology Finance Corporation (NASDAQ: HRZN) (Horizon) (the Company), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ...

Hyperfine, Inc. (NASDAQ:HYPR) Given Average Recommendation of "Hold" by Analysts

Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation a...

Hyperfine (NASDAQ:HYPR) Upgraded by Zacks Research to "Hold" Rating

Zacks Research raised Hyperfine to a "hold" rating in a research report on Thursday...

Lake Street Capital Forecasts Strong Price Appreciation for Hyperfine (NASDAQ:HYPR) Stock

Lake Street Capital boosted their price objective on shares of Hyperfine from $2.00 to $2.50 and gave the company a "buy" rating in a research note on Thursday...

Hyperfine Q4 Earnings Call Highlights

Hyperfine (NASDAQ:HYPR) reported fourth-quarter results that management said reflected accelerating adoption of its next-generation Swoop portable brain MRI system, driven by improved image quality...

Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results

Hyperfine (NASDAQ:HYPR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of...

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.

Current Price	$1.21
Prev Close	$1.21
Open	$1.23
Dividend Yield	0.00%
50-Day Moving Average	$1.14
Beta	1.52
Avg. Volume	630,570.58
PE Ratio	-2.72

52-Week High	$2.22
52-Week Low	$0.5327
Market Capitalization	$118.53M
EPS (Annual)	-$0.4349
Price to Book	2.87
Revenue Per Employee	$132,970.59

HYPR
Hyperfine Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HYPR News

HYPRHyperfine Inc - Ordinary Shares - Class A